2025 Analysis: Opportunities and Risks in the Evolving Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Sector?
The market for raw materials involved in the synthesis of messenger ribonucleic acid (mrna) has witnessed a slight expansion in recent years. It is projected to increase from $2.99 billion in 2024 to $3.03 billion in 2025, with a compound annual growth rate (CAGR) of 1.5%. The upward trend in the historic period can be credited to improvements in biomedical research, a surge in attention towards vaccines and therapeutic solutions, the requirement for personalized medical care, readiness and response to epidemic outbreaks, and the enlargement of the biotech industry.
Over the next several years, consistent growth is anticipated in the market size of the raw materials for messenger ribonucleic acid (mrna) synthesis. By 2029, it is projected to expand to “$3.48 billion at a compound annual growth rate (CAGR) of 3.5%.” Factors contributing to growth during the projected period could include optimization of supply chains, expansion of the commercial market, increased investment in biotech and pharma, regulatory backing and clearances, and expansion in therapeutics. Some of the leading trends forecasted for this period incorporate the introduction of new market players, enhancement in quality control and standardization, matters about intellectual property and licensure, ensuring global access and equity, and a move towards sustainable and scalable manufacturing.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What Forces Are Driving The Growth Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The surge in cancer and chronic diseases cases is anticipated to fuel the expansion of the mRNA synthesis raw materials market in the coming years. Cancer is characterized by the uncontrollable growth of rogue cells that have the potential to permeate neighbouring tissues and potentially spread to other body parts via the circulatory and lymphatic systems. Chronic diseases, on the other hand, are generalized as conditions that last for at least a year, requiring ongoing medical attention, disrupting daily operations, or both. mRNA synthesis raw materials contribute immensely to drug discovery, vaccine development, and the production of RNA-based therapeutics. The latter offers enhanced immunogenicity, superior efficiency, and short production time, making them ideal for the treatment of cancer and chronic conditions. Citing the American Cancer Society Facts and Figures, in 2022, around 1.9 million new instances of cancer were identified in the US, and there were 609,360 fatalities. The projections for 2023 show a marginal increase to more than 1.9 million new cases and approximately 609,820 deaths. Hence, the rising occurrences of cancer and chronic diseases contribute to the demand for mRNA synthesis of raw materials.
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
What Notable Trends Are Shaping The Direction Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Innovations in product design are being recognized as a significant trend in the mRNA synthesis raw materials industry. Important industry players are focusing their efforts on the development of novel products to solidify their market presence. To illustrate, Thermo Fisher Scientific, an American firm providing instrumentation, reagents, consumables, and software services, launched Dynabeads Solutions in September 2022. These are beads designed for scaling up GMP-grade synthesis and mRNA purification for vaccine development. Dynabeads Streptavidin for In Vitro Transcription are designed for easy solid-phase IVT of cell-free mRNA, simultaneously facilitating DNA template reuse up to six times and minimizing the need for plasmid creation. This increases mRNA yield on a variety of scales. Further, this development aids in the creation of a streamlined procedure that propels mRNA companies from the development phase to commercialization more rapidly.
Which Companies Currently Dominate The Competitive Landscape In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Industry?
Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market include Pfizer Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Moderna Inc., Agilent Technologies Inc., Lonza Group Ltd., Eurofins Scientific, Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Integrated DNA Technologies Inc., Sino Biological Inc., CureVac N.V., LGC Biosearch Technologies, Enzo Biochem Inc, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc, Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Which Geographic Regions Are Driving Demand In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
North America was the largest region in the mRNA synthesis raw materials market in 2024. The regions covered in the messenger ribonucleic acid (mRNA) synthesis raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
